Neuro-oncological patients' and caregivers' psychosocial burden during the COVID-19 pandemic-A prospective study with qualitative content analysis.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
09 2021
Historique:
revised: 11 04 2021
received: 25 01 2021
accepted: 12 04 2021
pubmed: 4 5 2021
medline: 11 9 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

The COVID-19 pandemic may reinforce psychosocial distress of neuro-oncological patients. We aimed to (1) differentiate the burden caused by the pandemic versus the tumor and (2) establish topics relevant for brain tumor patients (BTPs) and caregivers. Patients and caregivers were prospectively assessed from April 2020-July 2020 by a 10-item comprising interview over the phone, including qualitative and quantitative questions. They were quantitatively evaluated i.a. by the distress thermometer (DT, score 1-10). The qualitative questions were analyzed using structured content analysis: The interview questions defined the main categories. Subcategories were derived by an inductive approach assessing the frequency of patients' and caregivers' answers. A total of 69 patients and 20 caregivers were interviewed; n = 36 were female (49%), mean age was 53 years (range 32-81). Patients' disease-related DT scores were higher than the COVID-19-related DT scores: the median of the disease-related DT score was 7 (range 2-10) versus median of COVID-19-related distress: 5.0 (range 2-7). Caregivers perceived a higher burden due to the disease (DT median disease: 8; range 2-10 vs. DT pandemic: 3, range 0-10). A total of five main and 21 subcategories were elaborated, most frequently mentioned were "restrictions in public and private affairs" (28%), "changes in the psychological well-being" (23%), "limited social interaction by contact restriction" (25%). Subcategories relevant for caregivers were similar to those of BTPs. A considerable proportion of patients and caregivers still perceived the brain tumor disease as more burdensome than the pandemic. We established main and subcategories of interview items possibly of great relevance to patients during these difficult times, which could be implemented in the content-related adaption of the psychosocial assessment.

Identifiants

pubmed: 33938076
doi: 10.1002/pon.5713
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1502-1513

Subventions

Organisme : Bayer
ID : Unassigned
Organisme : Medac
ID : Unassigned

Informations de copyright

© 2021 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.

Références

Ford E, Catt S, Chalmers A, Fallowfield L. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-oncology. 2012;14(4):392-404.
Vargo M, Henriksson R, Salander P. Rehabilitation of patients with glioma. Handb Clin Neurol. 2016;134:287-304.
Sterckx W, Coolbrandt A, Dierckx de Casterlé B, et al. The impact of a high-grade glioma on everyday life: a systematic review from the patient's and caregiver's perspective. Eur J Oncol Nurs. 2013;17(1):107-117.
Piil K, Nordentoft S, Larsen A, Jarden M. Bereaved caregivers of patients with high-grade glioma: a systematic review. BMJ Support Palliat Care. 2019;9(1):26-33.
Parmet WE, Sinha MS. The law and limits of quarantine the new England. J Med. 2020;382(15).
Weller M, Preusser M. How we treat patients with brain tumour during the COVID-19 pandemic. ESMO Open. 2020;4(Suppl 2).
Rubin EJ, Baden LR, Morrissey S. Audio interview: new research on possible treatments for Covid-19. N Engl J Med. 2020;382(12):e30.
Rubin EJ, Baden LR, Morrissey S. Audio interview: practical measures to help prevent Covid-19. N Engl J Med. 2020;382(13):e32.
Millar C, Campbell S, Fisher P, Hutton J, Morgan A, Cherry MG. Cancer and COVID -19: patients' and psychologists' reflections regarding psycho-oncology service changes. Psychooncology. 2020;29(9):1402-1403.
Voisin MR, Oliver K, Farrimond S, et al. Brain tumors and COVID-19: the patient and caregiver experience. Neurooncol Adv. 2020;2(1):vdaa104.
Aaranson NK, Ahnedzai S, Bergman B, et al. The European organization for research and treatment of cancer QlQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5).
Glaser BG, Strauss AL. The discovery of grounded theory : strategies for qualitative research1967. A Division of Transaction Publishers, New Brunswick, USA; London
Holland JC, Jacobsen PB, Riba MB. NCCN: distress management. Cancer Control. 2001;8(6 Suppl 2):88-93.
Kuckartz U. Qualitative Content Analysis: From Kracauer's Beginnings to Today's Challenges. Forum Qualitative Sozialforschung / Forum: Qualitative Social Research. 2019;20(3):12. https://doi.org/10.17169/fqs-20.3.3370
Liu F, Huang J, Zhang L, et al. Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis. BMC Canc. 2018;18(1).
Goebel S, Mehdorn HM. Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol. 2011;104(1):357-364.
Stieb S, Fischbeck S, Wagner W, Appels J, Wiewrodt D. High psychosocial burden in relatives of malignant brain tumor patients. Clin Neurology Neurosurg. 2018;170:1-6.
Choi C-WJ, Stone RA, Kim KH, et al. Group-based trajectory modeling of caregiver psychological distress over time. Ann Behav Med. 2012;44(1):73-84.
Boele FW, Rooney AG, Bulbeck H, Sherwood P. Interventions to help support caregivers of people with a brain or spinal cord tumour. Cochrane Database Syst Rev. 2019;7(7):Cd012582.
Huang J, Zeng C, Xiao J, et al. Association between depression and brain tumor: a systematic review and meta-analysis. Oncotarget. 2017;8(55):94932-94943.
Finocchiaro CY, Petruzzi A, Lamperti E, et al. The burden of brain tumor: a single-institution study on psychological patterns in caregivers. J Neurooncol. 2012;107(1):175-181.
Schubart JR, Kinzie MB, Farace E. Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro Oncol. 2008;10(1):61-72.
Applebaum AJ, Kryza-Lacombe M, Buthorn J, DeRosa A, Corner G, Diamond EL. Existential distress among caregivers of patients with brain tumors: a review of the literature. Neurooncol Pract. 2016;3(4):232-244.
Renovanz M, Hechtner M, Janko M, et al. Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting. J Neurooncol. 2017;133(3):653-662.
Han J, Zhou F, Zhang L, Su Y, Mao L. Psychological symptoms of cancer survivors during the COVID-19 outbreak: a longitudinal study. Psycho Oncol. 2020.
Sannes TS, Yeh IM, Gray TF. Caring for loved ones with cancer during the COVID-19 pandemic: a double hit risk for social isolation and need for action. Psycho Oncol. 2020;29(9):1418-1420. https://doi.org/10.1002/pon.5466
Büssing A, Hübner J, Walter S, Gießler W, Büntzel J. Tumor Patients´ perceived changes of specific attitudes, perceptions, and behaviors due to the COVID-19 pandemic and its relation to reduced wellbeing. Front Psychiatr. 2020;11:574314.
Jazieh AR, Chan SL, Curigliano G, et al. Delivering cancer care during the COVID-19 pandemic: recommendations and lessons learned from ASCO global webinars. JCO Glob Oncol. 2020;6:1461-1471.
Bernhardt D, Wick W, Weiss SE, et al. Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas. Neuro Oncol. 2020;22(7):928-935.
Blue R, Yang AI, Zhou C, et al. Telemedicine in the era of coronavirus disease 2019 (COVID-19): a neurosurgical perspective. World Neurosurgery. 2020;139:549-557.

Auteurs

Julia Binswanger (J)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Carolin Kohl (C)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Felix Behling (F)

Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Susan Noell (S)

Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Sophie Hirsch (S)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Anne-Katrin Hickmann (AK)

Department of Neurosurgery, Universitat St Gallen Bibliothek, St. Gallen, Switzerland.

Marcos Soares Tatagiba (MS)

Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Ghazaleh Tabatabai (G)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Melina Hippler (M)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Mirjam Renovanz (M)

Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.
Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH